Evidence map›Paper›PMID 41577663›Full record

ArticleNature communications2026

NatA engages in multi-factor complexes at the ribosomal polypeptide tunnel exit.

Marius Klein, Klemens Wild, Nina McTiernan, Thomas Arnesen, Irmgard Sinning

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marius KleinHeidelberg University Biochemistry Center (BZH), Heidelberg, Germany.ORCID http://orcid.org/0000-0001-6956-0733
Klemens WildHeidelberg University Biochemistry Center (BZH), Heidelberg, Germany.ORCID http://orcid.org/0000-0001-9733-8187
Nina McTiernanDepartment of Biomedicine, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0002-1749-6933
Thomas ArnesenDepartment of Biomedicine, University of Bergen, Bergen, Norway.ORCID http://orcid.org/0000-0002-3005-147X
Irmgard SinningHeidelberg University Biochemistry Center (BZH), Heidelberg, Germany. irmi.sinning@bzh.uni-heidelberg.de.ORCID http://orcid.org/0000-0001-9127-4477

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) SI 586-6EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) Grant 772039Norges Forskningsråd (Research Council of Norway) FRIPRO Grant 324195
6 · The paper itself

Abstract

N-terminal acetylation (NTA) is the most common protein modification in eukaryotes, playing a crucial role in proteostasis. Almost 40% of the human proteome is acetylated co-translationally by the NatA complex, which requires prior N-terminal methionine excision (NME). Recently, NatA was shown to form multi-enzyme complexes with MAP1/NAC or MAP2, combining the capabilities of NME and NTA into a single complex. Here, we show that NatA can also form ribosome-independent assemblies with several ribosome associated factors (RAFs). At the ribosome, NatA can form a ternary complex with the abundant pseudoenzyme Ebp1 or a second copy of NatA, which can be coordinated from a different binding site with closer access to a potential substrate. Further, we identify a conserved binding site on NatA, which can be accessed by four RAFs - Ebp1, NAC, Naa10 and HypK, allowing the formation of different multi-factor complexes at the ribosomal tunnel exit. Therefore, our data suggest that NatA constitutes an interaction hub, and contributes to the coordination of co-translational protein maturation.

Indexed as

N-Terminal Acetyltransferase ERibosomesAcetylationBinding SitesChaetomiumHumansProtein BindingRibosomal ProteinsN-Terminal Acetyltransferase ERibosomal Proteins

Identifiers

PMID41577663
PMCPMC12830823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.